Immuno-bridging Study of Inactivated SARS-CoV-2 Vaccine in Healthy Population Aged 3-17 vs Aged 18 Years Old and Above

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a open label clinical trial to evaluate the efficacy, safety and immunogenicity of inactivated SARS-CoV-2 vaccines (Vero cell) in healthy people aged 3-17 years old in comparison with healthy population aged 18 years old and above
Epistemonikos ID: 3afa5fe9f9eaa272d185cbcdb3b4b1065d2768e1
First added on: Jun 09, 2021